159 related articles for article (PubMed ID: 36450989)
1. Molecular basis for selective activation of DREADD-based chemogenetics.
Zhang S; Gumpper RH; Huang XP; Liu Y; Krumm BE; Cao C; Fay JF; Roth BL
Nature; 2022 Dec; 612(7939):354-362. PubMed ID: 36450989
[TBL] [Abstract][Full Text] [Related]
2. The first structure-activity relationship studies for designer receptors exclusively activated by designer drugs.
Chen X; Choo H; Huang XP; Yang X; Stone O; Roth BL; Jin J
ACS Chem Neurosci; 2015 Mar; 6(3):476-84. PubMed ID: 25587888
[TBL] [Abstract][Full Text] [Related]
3. DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs
Thompson KJ; Khajehali E; Bradley SJ; Navarrete JS; Huang XP; Slocum S; Jin J; Liu J; Xiong Y; Olsen RHJ; Diberto JF; Boyt KM; Pina MM; Pati D; Molloy C; Bundgaard C; Sexton PM; Kash TL; Krashes MJ; Christopoulos A; Roth BL; Tobin AB
ACS Pharmacol Transl Sci; 2018 Sep; 1(1):61-72. PubMed ID: 30868140
[TBL] [Abstract][Full Text] [Related]
4. Effects of clozapine-N-oxide and compound 21 on sleep in laboratory mice.
Traut J; Mengual JP; Meijer EJ; McKillop LE; Alfonsa H; Hoerder-Suabedissen A; Song SH; Fehér KD; Riemann D; Molnar Z; Akerman CJ; Vyazovskiy VV; Krone LB
Elife; 2023 Mar; 12():. PubMed ID: 36892930
[TBL] [Abstract][Full Text] [Related]
5. Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys.
Nagai Y; Miyakawa N; Takuwa H; Hori Y; Oyama K; Ji B; Takahashi M; Huang XP; Slocum ST; DiBerto JF; Xiong Y; Urushihata T; Hirabayashi T; Fujimoto A; Mimura K; English JG; Liu J; Inoue KI; Kumata K; Seki C; Ono M; Shimojo M; Zhang MR; Tomita Y; Nakahara J; Suhara T; Takada M; Higuchi M; Jin J; Roth BL; Minamimoto T
Nat Neurosci; 2020 Sep; 23(9):1157-1167. PubMed ID: 32632286
[TBL] [Abstract][Full Text] [Related]
6. Side-by-side comparison of the effects of Gq- and Gi-DREADD-mediated astrocyte modulation on intracellular calcium dynamics and synaptic plasticity in the hippocampal CA1.
Van Den Herrewegen Y; Sanderson TM; Sahu S; De Bundel D; Bortolotto ZA; Smolders I
Mol Brain; 2021 Sep; 14(1):144. PubMed ID: 34544455
[TBL] [Abstract][Full Text] [Related]
7. Chemogenetic Activation of Excitatory Neurons Alters Hippocampal Neurotransmission in a Dose-Dependent Manner.
Pati S; Salvi SS; Kallianpur M; Vaidya B; Banerjee A; Maiti S; Clement JP; Vaidya VA
eNeuro; 2019; 6(6):. PubMed ID: 31645362
[TBL] [Abstract][Full Text] [Related]
8.
Hu F; Morris PJ; Bonaventura J; Fan H; Mathews WB; Holt DP; Lam S; Boehm M; Dannals RF; Pomper MG; Michaelides M; Horti AG
Eur J Med Chem; 2021 Mar; 213():113047. PubMed ID: 33280897
[TBL] [Abstract][Full Text] [Related]
9. Chemogenetics revealed: DREADD occupancy and activation via converted clozapine.
Gomez JL; Bonaventura J; Lesniak W; Mathews WB; Sysa-Shah P; Rodriguez LA; Ellis RJ; Richie CT; Harvey BK; Dannals RF; Pomper MG; Bonci A; Michaelides M
Science; 2017 Aug; 357(6350):503-507. PubMed ID: 28774929
[TBL] [Abstract][Full Text] [Related]
10. Perturbing cortical networks:
Kovács P; Beloate LN; Zhang N
Front Neurosci; 2024; 18():1396978. PubMed ID: 38726028
[TBL] [Abstract][Full Text] [Related]
11. Behavioral Effect of Chemogenetic Inhibition Is Directly Related to Receptor Transduction Levels in Rhesus Monkeys.
Upright NA; Brookshire SW; Schnebelen W; Damatac CG; Hof PR; Browning PGF; Croxson PL; Rudebeck PH; Baxter MG
J Neurosci; 2018 Sep; 38(37):7969-7975. PubMed ID: 30082415
[TBL] [Abstract][Full Text] [Related]
12. [A novel ligand for chemogenetic receptors, Deschloroclozapine, enables rapid and selective modulation of neuronal activity and behavior in living animals].
Nagai Y
Nihon Yakurigaku Zasshi; 2022; 157(4):233-237. PubMed ID: 35781451
[TBL] [Abstract][Full Text] [Related]
13. Cre-dependent DREADD (Designer Receptors Exclusively Activated by Designer Drugs) mice.
Zhu H; Aryal DK; Olsen RH; Urban DJ; Swearingen A; Forbes S; Roth BL; Hochgeschwender U
Genesis; 2016 Aug; 54(8):439-46. PubMed ID: 27194399
[TBL] [Abstract][Full Text] [Related]
14. DREADD: a chemogenetic GPCR signaling platform.
Zhu H; Roth BL
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25522378
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural localization of DREADDs in monkeys.
Galvan A; Raper J; Hu X; Paré JF; Bonaventura J; Richie CT; Michaelides M; Mueller SAL; Roseboom PH; Oler JA; Kalin NH; Hall RA; Smith Y
Eur J Neurosci; 2019 Sep; 50(5):2801-2813. PubMed ID: 31063250
[TBL] [Abstract][Full Text] [Related]
16. Chronic Behavioral Manipulation via Orally Delivered Chemogenetic Actuator in Macaques.
Oyama K; Hori Y; Nagai Y; Miyakawa N; Mimura K; Hirabayashi T; Inoue KI; Takada M; Higuchi M; Minamimoto T
J Neurosci; 2022 Mar; 42(12):2552-2561. PubMed ID: 35110390
[TBL] [Abstract][Full Text] [Related]
17. Effect of chemogenetic actuator drugs on prefrontal cortex-dependent working memory in nonhuman primates.
Upright NA; Baxter MG
Neuropsychopharmacology; 2020 Oct; 45(11):1793-1798. PubMed ID: 32193513
[TBL] [Abstract][Full Text] [Related]
18. In vivo electrophysiological validation of DREADD-based modulation of pallidal neurons in the non-human primate.
Deffains M; Nguyen TH; Orignac H; Biendon N; Dovero S; Bezard E; Boraud T
Eur J Neurosci; 2021 Apr; 53(7):2192-2204. PubMed ID: 32306446
[TBL] [Abstract][Full Text] [Related]
19. The use of chemogenetic approaches in alcohol use disorder research and treatment.
Cheng Y; Wang J
Alcohol; 2019 Feb; 74():39-45. PubMed ID: 30442535
[TBL] [Abstract][Full Text] [Related]
20. Resting-State fMRI-Based Screening of Deschloroclozapine in Rhesus Macaques Predicts Dosage-Dependent Behavioral Effects.
Fujimoto A; Elorette C; Fredericks JM; Fujimoto SH; Fleysher L; Rudebeck PH; Russ BE
J Neurosci; 2022 Jul; 42(29):5705-5716. PubMed ID: 35701162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
